Jennifer Clancy Joins Lonza as Head of Global Marketing


South Plainfield, NJ (USA) - 17 April 2018
Jennifer Clancy has joined Lonza’s Consumer Product Ingredients (CPI) business as Senior Director of Global Marketing. She was introduced to customers at in-cosmetics Global 2018 at the Lonza Stand E80, from 17-19 April in Amsterdam. (NL).

Based in Allendale, NJ (USA), Clancy is responsible for strategic development and execution of all marketing initiatives to support lead generation, growth, and value creation within the CPI business. She oversees the planning and execution of initiatives across marketing and competitive intelligence, consumer and trade research, brand management, new product launches, marketing communications, event management, web content, sales force support and customer engagement. Clancy is a member of the CPI Leadership Team.

Clancy comes t o Lonza with more than 20 years of experience in the consumer products industry. Throughout her career she has held key marketing and brand management roles at companies including Estée Lauder, Elizabeth Arden and International Flavors & Fragrances. Most recently, Clancy was Global Director, Creative
Marketing Studio at Firmenich, Inc.

A graduate of Fashion Institute of Technology in New York, Clancy is an active member of Cosmetic Executive Women and Associate Board Member of the Fragrance Foundation and The Fashion Group International.

About Lonza Consumer Product Ingredients - Personal Care
Part of Lonza’s Consumer Product Ingredients business unit, the Personal Care business is a world’s leading supplier of active antidandruff agents, with its ZincOmadine® product considered the gold standard in the antidandruff shampoo market. Lonza Personal Care also supplies a wide array of other hair- and skin-care products, including biotechnology-derived active ingredients, preservatives for use in certified natural and organic products, specialty esters, functional ingredients and more. More information on these products can be found at

About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer's healthy environment.

Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.

Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fastmoving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources.

Founded in 1897 in the Swiss Alps, Lonza today is a wellrespected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion. Further information can be found at

« back